ArticleExperimental and therapeutic medicine2025
Impact of obesity and diabetes on colorectal cancer in Saudi Arabia is associated with liver γ‑glutamyl transferase abnormality.
Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- The rising burden of obesity-linked cancers in Saudi Arabia: a public health review.Annals of medicine and surgery (2012) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) is a leading global cause of death. In Saudi Arabia, it is the most common cancer among men and the third most common among women. Obesity, diabetes and CRC have become significant health concerns. The present study aimed to explore the connection between liver function markers, obesity and diabetes in patients with CRC. In addition to exploring whether the incidence of CRC had increased in Saudi Arabia. The present study conducted a retrospective chart review based on data from the Saudi Ministry of National Guard Hospitals. Clinical laboratory assays of patients with CRC with obesity and/or diabetes between 2015 and 2021 were analysed, and various factors were considered. This study found that CRC is more prevalent in overweight and obese individuals, primarily aged 50 years and older. Diabetes was more common in patients with CRC (61.76%) compared with non-diabetic individuals (38.24%). Additionally, the protein γ-glutamyl transferase might serve as a potential biomarker for CRC in overweight and obese patients. Notably, the age of CRC diagnosis in Saudi Arabian patients in the present study was lower than previously reported. The present study provided insight into the relationship between obesity, diabetes and liver function markers in Saudi Arabian patients with CRC. It also highlighted the increasing incidence of CRC in Saudi Arabia, emphasizing the need for further attention and research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.